]oestradiol) the following sample estjmates were obtained: n = 100, r = 0.982, yi = 3.04 -h 1.00035 x. For a 0.95 probability of confidence it can be stated that the sample estimates are indeed comparabje according to the criteria of the two ligands.
I]Oestradiol äs Ligands for Oestrogen Receptor Determination
By H.-J. Grill I]3,17ß-oestradiol was investigated for its suitability for routine oestrogen receptor determinations. Unlabeled 16a-iodo-oestradiol was synthesized. No difference in the relative binding affinity to human üterine oestrogen receptor could be demonstrated, but unlabeled äs well äs labeled 16a-iodo-oestradiol do not bind to serum sex hormone binding globulin. At 0-4°C [ 3 H]oestradiol reaches, when incubated with oestrogen receptor its equilibriuni after 3 h, [
125 I]oestradiol after 9 h.
In 100 human mammary tumour cytosols oestrogen receptor concentrations were determined using either 
Iiitroduction
The oestrogen receptor content of a human mammary tuiiiour has proved to be a valuable parameter for the selection of a patient's therapy (hormone or chemotherapy). Approximately 68% of all human breast tumours contain significant ainpunts of oestrogen receptor (< 10 fmol/mg cytosol protein). 65% of patients with oestrogen receptor-positive tumours respond to hormonal manipulation (1-7). Additional Information for prediction of response to hormone therapy can be obtained by determination of progesterone receptors. On the "Consensus Meeting on Steroid Receptors in Breast Cancer" (8) the dextran coated charcoal assay (9) and the sucrose density gradient analysis (10) were generally accepted äs ideal routine methods for steroid receptor determinations. Recently, a radio-iodinated derivative of oestradiol was synthesized (11, 12) . Initial studies indicated that its performance in the oestrogen receptor assay is equivalent to that of tritium-labeled oestradiol (13, 14) . In the present study the binding characteristics of commercially available [16a-125 I]3,17ß-oestradiol and of [ 3 H]3,17ß-oestradiol were investigated. We compared the binding of the two ligands tp human sex hormone binding globulin, the rate of äs-sociation with human uterine oestrogen receptor, the binding specificity and oestradiol receptor concentrations in 100 human mammary tumour cytosols. 1 and the tritium reference sources for calibration of the scintillation counter were purchased from New England Nuclear (Boston, M A 02118). Unlabeled steroids äs well äs diethylstilboestrol were purchased from Serva (Heidelberg, F.R.G.). All other chemicals were of reagent grade. Scintillation cocktail was from Zinsser (Heidelberg, F.R.G.). Protein Standard was from BIO-RAD Laboratories (Richmond, CA 94804).
Materials and Methods

Reagents
Assay buffer 10mmol/l K 2 HPO 4 , 10mmol/l KH 2 PO 4 , 1.5 mmol/1 disodiumethylene-diaminetetraacetate, 3 mmol/1 sodium azide, 100 g/l glycerol, pH 7.5. Dextran-coated charcoal Suspension: Norit A, 5g/l, Dextran T-500 0.5 g/l in assay buffer, pH 7.5.
Preparation of cytosol
The tissues were pulverized in a micro dismembrator (Braun Melsungen), extracted with assay buffer and centrifuged for 30 min at 105000g. The supernatant was taken äs cytosol.
Oestrogen receptor control powder
An oestrogen receptor control powder was purchased from New England Nuclear. It contained 76 ± 24 fmol/mg protein äs determined by the manufacturer. The lyophilized animal tissue powder was suspended in assay buffer and centrifuged äs described above. These reference powders fulfill the criteria of American quality control.
Synthesis of nonlabeled 16a-iodo-oestradiol 16a-Bromo-3-methoxyoestra-l,3,5(10)-triene-17-one: This compound, m.p. 175-177 °C, was prepared by bromination of estrone methylether with cupric bromide.
16ß-Bromo-3-methoxyoestra-l,3,5(10)-triene-3,17ß-diol: This compound, m.p. 113-115°C, was prepared by epimerization of the prece'ding compound with potassium bromide in dimethylformamide, followed by reduction with sodium borohydride in methanol (15) . 16a-Iodo-oestra-l,3,5(10)-triene-3 ? 17ß-diol(16a-iodo-oestradl· ol): 16ß-Bromooestra-l,3,5(lO)-triene-3;i7ß-dioi (0.735g, 2 mmol) and sodium iodide (0.33 g, 2.2 mmol) were dissolved in methyl ethyl ketone (10 ml) and the reaction mixture was heated at 70 °C overnight. The liquid was poured into water (150 ml) arid extracted with methylene chloride (3 x 30 ml). The extracts were successively washed with diluted sodium thiosulphatd and water, dried with sodium sulphate and evaporated. The residue was recrystallized from ethanol, m.p. 190-192 °C (11).
Cornpetition assay
Competitors
The following compounds were investigated for their relative binding affinities fpr the human uterine oestrogen receptor: oest radiol, diethylstilboestrol, 16ß-bromo-oestradiol, 16<Xrio<kHoes-tradiol. The tubes were prepared äs follows: To each tube 50 of [ 3 H]oestradiol (in assay buffer) was pipetted to give a final concentration of 8 nmol/1. Then aliquots of 50 containing the variöus competitors (in assay buffer) at 6 different concentrations (ränge 0.1 nmol/1-10 /l) were added. Finally, to each tube 100 pf human uterine cytosol were added and after gentle shaking the tubes were incubated overnight at 4 °C. The reactions were terminated by the addition of 0.5 ml dextran coated chafcoaHus* pension. After 10 min of incubation under gentle shaking the tubes were centrifuged for 10 min at 1500g. 0.5 ml of the supern atant were transferred to seiiitillatipn vials and after addition of 10 ml scintillation cpcktail they were cöurited for radioactivity. Ali deterfninations were carried out in triplieate.
Binding to human sex hormone binding globulin (SHGB)
Human pregnancy serum was stripped with charcoal of endogenous steroids. The serum was used in a dilution with assay buffer of l : 10. The following compounds were investigated for their relative binding affinities: dihydrotestosterone, 3,17ß^oestradiol, 16ß-rbromo-3,17ß-oestradiol, 16ct-iodo-3, l 7ß-oesträdipl. To each tube 50 of [ 3 H]dihydrotestosterone (in assay buffer) was pipetted to give a final concentration of 8 nmol/1. Aliquots of 50 containing the various competitors (in assay buffer) at 6 different concentrations (ränge 0.1 nmol/I-10 >1/1) and -diluted serum were added. After incubäting for 60 min at room temperature plus 10 min in an ice-bath, 0.5 ml of dextran coated charcoal Suspension were added and the tubes were treated äs described above.
Rate of association
The time course of binding of [ dextran coated charcoaNsuspension. The tubes were incubated under gentle shaking for 10 min at 4 °C followed by 10 min centrifüga-tion at 1500 g. 0.5 ml aliquots of the supernatant were transferred into scintillation vials and counted for radioactivity after the addl· tion öf 10 ml of scintillation cocktail. 0-4 °C. To remove the unbound stcroid, 500 μΐ of dextran-coated charcoal werc added to each tube and incubated for 10 min under gcntle shaking. After centrifugation, 500 ,μΐ of the supernatant were withdrawn and counted for radioactivity in a Beckman LS 7500. The liquid Stimulation counter was calibrated using tritium and I25 1 reference sources with known radioactivity (min" 1 ) val es.
Protein assay
The protein concentrations of the cytosols were determined according to the method of Waddell (17) . A ΒΙΟ-RAD protein Standard was used for the Standard curve.
Calculation of the results
All data were expressed s disintegrations per minute (min" 1 ) and were transformed according to the method of Scatchard (18) . For this transformation the Computer program of Schwarz (19) and a HP 97 calculator (Hewlett Packard) was used. For each titration curve the K<j-value, correlation coefficient (by linear regression), intercept on the abscissa (equal to the molar concentration of binding sites) and the oestradiol receptor concentrations (fmol/mg cytosol protein) were calculatcd.
Results and Discussion
The new ligand 16a-iodo-3,17 -oestradiol has to be carefully characterized prior to use for routine oestradiol receptor assay. It provides several advantages compared to [ fig. 4) . 20 of these contained oestradiol receptor levels below 5 fmol/mg proteiri, which was taken s the detection limit. Taking IQ fmol/mg protein s the clinical cut off level for being oestradiol receptor positive j orte out of 100 was found to be false positive and 2 out of 100 false negative, when the [ 3 H]oestradiol assay was used. If one assumes an equivalency of the two ligands the siope of the regression should be 45°. The factor of proportionality would then be 1.0 and the regression line should pass thrpugh the origin. This would further imply that the coefficierit f regression a is only randomly different from 0 and the coefficient of regression b is only randomly different from 1.0. To check this assumption a joint confidehce region for the parameters a and b of the regression line was calculated according to Brownlee (22) 
